Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
about
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model.Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics.Aripiprazole Lauroxil: A Review in Schizophrenia.Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications.
P2860
Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Aripiprazole Lauroxil: Pharmac ...... in Persons With Schizophrenia
@en
type
label
Aripiprazole Lauroxil: Pharmac ...... in Persons With Schizophrenia
@en
prefLabel
Aripiprazole Lauroxil: Pharmac ...... in Persons With Schizophrenia
@en
P2093
P2860
P1476
Aripiprazole Lauroxil: Pharmac ...... in Persons With Schizophrenia
@en
P2093
Brian M Sadler
Leslie Citrome
Marjie L Hard
Richard J Mills
Ryan Z Turncliff
P2860
P304
P356
10.1097/JCP.0000000000000691
P407
P577
2017-03-27T00:00:00Z